Weight loss and exercise to improve rheumatoid arthritis cardiovascular risk
减肥和运动可改善类风湿性关节炎心血管风险
基本信息
- 批准号:10663627
- 负责人:
- 金额:$ 14.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-15 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdherenceAdipose tissueAerobicAgeArthralgiaBlood GlucoseBlood PressureBody CompositionBody Weight decreasedBody mass indexCardiopulmonaryCardiovascular DiseasesCell physiologyCellsClinicalClinical TrialsCounselingDietitianDiseaseEducational InterventionExerciseExercise TestFastingFatigueFatty acid glycerol estersFutureGlucoseGoalsHealthHigh Density Lipoprotein CholesterolImmuneInflammationInflammatoryInformation SystemsInsulinInterventionInvestigationLeadLipoproteinsMeasurementMeasuresMedication ManagementMetabolic syndromeModelingMuscle functionObesityOutcomeOverweightPainParticipantPatient Outcomes AssessmentsPatient Self-ReportPatientsPersonsPharmacological TreatmentPhysical FunctionPhysical activityPositioning AttributeRandomizedReportingResistanceRheumatismRheumatoid ArthritisRiskRisk FactorsSafetySideSkeletal MuscleSupervisionSupport GroupsSystemTimeTrainingTraining ProgramsTriglyceridesWorkarmbasecardiometabolic riskcardiometabolismcardiovascular disorder riskcardiovascular healthcardiovascular risk factorclinical caredesigndiet and exerciseexercise interventionexercise trainingfunctional gainglobal healthhealth disparityimprovedinflammatory markerinsulin sensitivitymacrophagemonocytemortalityobese personphysical inactivitypost interventionprimary outcomeprogramsrecruitseropositivestandard of carestrength trainingsystemic inflammatory responsetreatment programwaist circumference
项目摘要
Despite recent, revolutionary improvements in pharmacologic management, rheumatoid arthritis (RA) remains
associated with increased rates of cardiovascular disease and mortality. RA cardiovascular risk results from a
combination of traditional risk factors and RA-related systemic inflammation. Consequently, to improve overall
RA cardiovascular risk, efforts should target both traditional risk factors and inflammation. One hypothetical
means of improving overall RA cardiovascular risk is through weight loss and physical activity. Together,
weight loss and physical activity can improve traditional cardiometabolic health through fat mass loss and
skeletal muscle quality and functional gains. Additionally, disease-related cardiovascular risk will improve as
both fat mass loss and exercise reduce systemic inflammation. To explore this hypothesis, 26 older,
overweight to obese persons with RA will be randomized to a control intervention based on traditional clinical
counselling or to a supervised weight loss plus exercise training program (3 times per week). Weight loss will
occur via a dietitian-led intervention targeting 7% weight loss over 16 weeks, with weekly weigh-ins and group
support sessions. Exercise training will consist of three times per week of an interval-based aerobic program
plus twice-weekly resistance training. Both weight loss and exercise training will be supervised to maximize
safety and adherence. The primary cardiometabolic outcome is a highly validated metabolic syndrome z-score,
calculated from blood pressure, waist circumference, HDL-cholesterol, triglycerides, and glucose. RA-related
cardiovascular risk will be assessed with measures of systemic inflammation, RA disease activity, and
macrophage function – key cells at the nexus of rheumatic and cardiovascular disease activity. Intervention
impacts on self-reported outcomes will be assessed with validated measures from the Patient Reported
Outcomes Measurement Information System (PROMIS). This exploratory clinical trial will show whether a
supervised intervention with weight loss and exercise training improves objective assessments of RA
cardiovascular risk, disease activity and results in patients reporting overall improved health. This investigation
will establish feasibility, acceptance, compliance, fidelity, and generate effects sizes critical for designing larger
RA interventions, especially those comparing weight loss and physical activity amounts and types. Also, by
demonstrating that weight loss with physical activity not only improves RA-associated cardiovascular risk and
disease activity, but also patient-reported global health, this work should provide immediate and long-lasting
impacts on RA clinical care.
尽管最近在药物管理方面取得了革命性的进步,但类风湿性关节炎 (RA) 仍然存在
与心血管疾病发生率和死亡率增加有关。
结合传统危险因素和 RA 相关全身炎症测试,以改善整体情况。
RA 心血管风险,应同时针对传统危险因素和炎症。
改善总体 RA 心血管风险的方法是减肥和体育锻炼。
减肥和体力活动可以通过减少脂肪量和改善传统的心脏代谢健康
此外,骨骼肌质量和功能增强,与疾病相关的心血管风险也会改善。
减少脂肪量和全身锻炼都可以减少炎症,以探索这一假设,26 岁,
超重至肥胖的 RA 患者将被随机分配至基于传统临床的对照干预组
咨询或监督减肥加运动训练计划(每周减肥3次)。
通过营养师主导的干预措施进行,目标是在 16 周内减轻 7% 的体重,每周称重并进行分组
支持课程包括每周三次的间歇性有氧运动。
加上每周两次的阻力训练,减肥和运动训练都会受到监督,以最大限度地发挥作用。
主要心脏代谢结果是经过高度验证的代谢综合征 z 评分,
根据血压、腰围、HDL 胆固醇、甘油三酯和 RA 相关的血糖计算。
心血管风险将通过全身炎症、RA 疾病活动度和
巨噬细胞功能——风湿病和心血管疾病干预的关键细胞。
对自我报告结果的影响将通过患者报告的有效措施进行评估
结果测量信息系统(PROMIS)。这项探索性临床试验将显示是否
减肥和运动训练的监督干预可改善 RA 的客观评估
报告健康状况整体改善的患者的心血管风险、疾病活动和结果。
将建立可行性、可接受性、合规性、保真度,并产生对大型设计至关重要的效果尺寸
RA 干预措施,特别是那些比较体重减轻和体力活动量和类型的干预措施。
证明通过体力活动减轻体重不仅可以改善与 RA 相关的心血管风险,
疾病活动,以及患者报告的全球健康状况,这项工作应该提供即时和持久的信息
对 RA 临床护理的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KIM M. HUFFMAN其他文献
KIM M. HUFFMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KIM M. HUFFMAN', 18)}}的其他基金
ENHANCING THE CALERIE NETWORK TO ADVANCE AGING BIOLOGY
加强 CALERIE 网络以推进衰老生物学
- 批准号:
10348707 - 财政年份:2021
- 资助金额:
$ 14.73万 - 项目类别:
ENHANCING THE CALERIE NETWORK TO ADVANCE AGING BIOLOGY
加强 CALERIE 网络以推进衰老生物学
- 批准号:
10649887 - 财政年份:2021
- 资助金额:
$ 14.73万 - 项目类别:
ENHANCING THE CALERIE NETWORK TO ADVANCE AGING BIOLOGY
加强 CALERIE 网络以推进衰老生物学
- 批准号:
10584573 - 财政年份:2021
- 资助金额:
$ 14.73万 - 项目类别:
Weight loss and exercise to improve rheumatoid arthritis cardiovascular risk
减肥和运动可改善类风湿性关节炎心血管风险
- 批准号:
10190841 - 财政年份:2020
- 资助金额:
$ 14.73万 - 项目类别:
Weight loss and exercise to improve rheumatoid arthritis cardiovascular risk
减肥和运动可改善类风湿性关节炎心血管风险
- 批准号:
9884906 - 财政年份:2020
- 资助金额:
$ 14.73万 - 项目类别:
Mechanisms of Insulin Resistance in Rheumatoid Arthritis
类风湿关节炎的胰岛素抵抗机制
- 批准号:
8319616 - 财政年份:2008
- 资助金额:
$ 14.73万 - 项目类别:
Mechanisms of Insulin Resistance in Rheumatoid Arthritis
类风湿关节炎的胰岛素抵抗机制
- 批准号:
7530481 - 财政年份:2008
- 资助金额:
$ 14.73万 - 项目类别:
Mechanisms of Insulin Resistance in Rheumatoid Arthritis
类风湿关节炎的胰岛素抵抗机制
- 批准号:
8123308 - 财政年份:2008
- 资助金额:
$ 14.73万 - 项目类别:
Mechanisms of Insulin Resistance in Rheumatoid Arthritis
类风湿关节炎的胰岛素抵抗机制
- 批准号:
7685420 - 财政年份:2008
- 资助金额:
$ 14.73万 - 项目类别:
Mechanisms of Insulin Resistance in Rheumatoid Arthritis
类风湿关节炎的胰岛素抵抗机制
- 批准号:
7914168 - 财政年份:2008
- 资助金额:
$ 14.73万 - 项目类别:
相似国自然基金
基于保护动机理论的新确诊青少年HIV感染者抗病毒治疗依从性“游戏+”健康教育及作用机制研究
- 批准号:82304256
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于前景理论的ADHD用药决策过程与用药依从性内在机制研究
- 批准号:72304279
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于强化学习AI聊天机器人对MSM开展PrEP服药依从性精准干预模式探索及干预效果研究
- 批准号:82373638
- 批准年份:2023
- 资助金额:59 万元
- 项目类别:面上项目
基于HAPA理论的PCI术后患者运动依从性驱动机制与干预方案构建研究
- 批准号:72304180
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CAS理论视角下农村老年心血管代谢性共病管理依从性的社区-患者协同机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Weight loss and exercise to improve rheumatoid arthritis cardiovascular risk
减肥和运动可改善类风湿性关节炎心血管风险
- 批准号:
10190841 - 财政年份:2020
- 资助金额:
$ 14.73万 - 项目类别:
Weight loss and exercise to improve rheumatoid arthritis cardiovascular risk
减肥和运动可改善类风湿性关节炎心血管风险
- 批准号:
9884906 - 财政年份:2020
- 资助金额:
$ 14.73万 - 项目类别:
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma
BMP4 工程间充质干细胞治疗胶质母细胞瘤
- 批准号:
9188284 - 财政年份:2015
- 资助金额:
$ 14.73万 - 项目类别:
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma
BMP4 工程间充质干细胞治疗胶质母细胞瘤
- 批准号:
9065529 - 财政年份:2015
- 资助金额:
$ 14.73万 - 项目类别:
Regulation of Maternal Fuel Supply and Neonatal Adiposity
母体燃料供应和新生儿肥胖的调节
- 批准号:
8449685 - 财政年份:2010
- 资助金额:
$ 14.73万 - 项目类别: